Market Access How are the US MFN and German MFG likely to impact pharmaceu... A comparison of the US MFN and German MFG.
Sales & Marketing Unlocking pharma launch potential: Integrated data strategie... Launch teams need real-time, integrated intelligence to navigate tighter markets, faster timelines, and rising expectations.
Market Access Sponsored The stealth market access strategy that’s quietly making man... There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.
Sales & Marketing Sponsored Beyond the launch date: Why pharma must rethink readiness fo... Explore why pharma companies must rethink their NHS strategies post-launch, with tools like IQVIA'S Market Access Launch Pad.
Sales & Marketing 5 Things to watch at Fierce Pharma Week 2025: What every pha... Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.
Sales & Marketing Sponsored Maintaining focus to prosper in a complex and rapidly evolvi... Launching a product is always an intense, pivotal moment, but in a fast moving era of scientific advances and regulatory change, it has become an even more critical enterprise.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
